| |
|
|
| |
OMB APPROVAL |
|
| |
OMB Number: 3235-0145
|
|
| |
Expires: February 28, 2009 |
|
| |
Estimated average burden
hours per response ... 10.4 |
|
| |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
StatSure Diagnostic Systems, Inc.
(Name of Issuer)
Common Stock, $0.001
(Title of Class of Securities)
795427202
(CUSIP Number)
October 20, 2007
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| |
o |
|
Rule 13d-1(b) |
| |
| |
þ |
|
Rule 13d-1(c) |
| |
| |
o |
|
Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on
this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for
the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to
the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
| |
|
|
|
|
|
|
|
|
|
|
CUSIP No. |
|
795427202 |
|
Page |
|
3 |
|
of |
|
5 Pages |
Item 1.
(a) Name of Issuer: StatSure Diagnostic Systems, Inc. (the “Issuer”).
(b) Address of the Issuer’s Principal Executive Offices: 1881 Worcester Road, #200, Framingham, MA
01701.
Item 2.
(a) Name of Person Filing: Inverness Medical Innovations, Inc.
(b) Address of Principal Business Office: 51 Sawyer Road, Suite 200, Waltham, MA 02453.
(c) Citizenship: Delaware
(d) Title and Class of Securities: Common stock, $0.001 (“Common Stock”)
(e) CUSIP Number: 795427202
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether
the person filing is a:
Not applicable
Item 4. Ownership
In the aggregate, as of October 20, 2007, the Reporting Person beneficially owns 2,499,999 shares
of Common Stock of the Issuer, representing approximately 6.1% of the class. The beneficial
ownership of the Reporting Person includes:
| |
(i) |
|
1,428,571 shares of the issued and outstanding Common Stock; and |
| |
| |
(ii) |
|
a warrant to acquire 1,071,428 shares of Common Stock. |
The
Reporting Person has (or will have) the sole power to vote and
dispose of all such beneficially owned shares.
Item 5. Ownership of Five Percent or Less of a Class
Not applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company or Control Person
Not applicable
| |
|
|
|
|
|
|
|
|
|
|
CUSIP No. |
|
795427202 |
|
Page |
|
4 |
|
of |
|
5 Pages |
Item 8. Identification and Classification of Members of the Group
Not applicable
Item 9. Notice of Dissolution of Group
Not applicable
Item 10. Certification
By signing below I hereby certify that, to the best of my knowledge and belief, the securities
referred to above were not acquired and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction having that purpose.